T he inflammasome is a pattern recognition complex that acts to coordinate immediate innate immune responses to invading microorganisms, metabolic perturbations, and tissue damage. Direct or indirect sensing of microbial-or dangerassociated molecular patterns triggers the assembly of an inflammasome, resulting in nucleation and autoactivation of the effector protease caspase-1. Active caspase-1 cleaves a number of substrates, including the cytokines pro-IL-1b and pro-IL-18, to initiate the inflammatory cascade and, in some contexts, a rapid form of cell death termed "pyroptosis." The related protease caspase-11 (human caspase-4) also was implicated in the induction of pyroptosis (1) and cytokine production (2, 3) in response to microbial stimuli, such as Escherichia coli, Citrobacter rodentium, or Vibrio cholera, or in the context of chemically induced colitis. Caspase-11 also was shown to confer protection from bacteria that escape the phagosome (4-7), and it acts as a direct sensor of intracellular LPS (8) .
Although inflammasome sensors, in particular NLRP3, react to danger signals released from damaged tissues, conversely, sustained inflammation and excessive pyroptosis can result in bystander tissue destruction, leading to a dangerous feed-forward cycle (9, 10) . This is best illustrated in patients carrying missense mutations in NLRP3 that render the inflammasome hyperactive, culminating in a spectrum of autoinflammatory disorders collectively termed "cryopyrin-associated periodic syndromes" (11) . These conditions manifest in multiorgan inflammation, including urticarial rash, amyloidosis, and debilitating CNS defects. Recently, mutations in the bacterial peptidoglycan sensor NLRC4 were associated with a similar multiorgan autoinflammatory disorder (12, 13) . Likewise, mouse models illustrated the importance of tight inflammasome control, because genetic ablation of negative regulators (14, 15) or transgenic expression of spontaneously active inflammasomes (16) (17) (18) resulted in severe bone disease, enhanced neuroinflammation, and dermatitis.
Atopic dermatitis (AD) and psoriasis are two inflammatory disorders that have steadily been on the rise in industrialized countries for the past three decades (19) . Although it is well documented that defects in skin barrier integrity, as seen in patients with mutations in the epidermal filaggrin gene FLG (20) , increase exposure to environmental allergens and irritants, the immune component of these diseases is not fully understood. This is especially significant because a large proportion of infants developing AD progress to other systemic atopic and allergic disorders, in a process termed "the atopic march" (21) . Notably, of the immune genes identified in genome-wide association studies, the IL1RL1-IL18R1-IL18RAP genetic locus was strongly associated with AD in a cohort of Japanese patients (22) .
Mouse models investigating the roles of cell death effectors revealed that skin homeostasis is critically dependent on tight control of cell death pathways. For instance, genetic ablation of necroptosis inhibitors gave rise to drastic inflammation in the skin and other epithelial sites (23, 24) . Similarly, although apoptosis is classically perceived as an anti-inflammatory cell death, recent genetic evidence illustrated that excessive apoptosis in the skin is likewise pathogenic (25) (26) (27) .
The linear ubiquitin assembly complex (LUBAC) plays a critical role downstream of various cytokine receptors and pattern recognition receptors by modifying RIPK1 and IKKg (NEMO) with linear polyubiquitin chains to promote inflammation and cell survival. LUBAC consists of two catalytic subunits, HOIP and HOIL-1, and a regulatory subunit: SHANK-associated RH domaininteracting protein (Sharpin). Interestingly, mice deficient in the different LUBAC components display radically different phenotypes; Hoil1 2/2 mice are viable and phenotypically normal (28), Hoip 2/2 mice die during embryogenesis at midgestation (29) , and a homozygous inactivating mutation in Sharpin triggers development of severe multiorgan inflammation, with the most prominent feature being chronic proliferative dermatitis (cpdm) (30) (31) (32) (33) . Sharpin cpdm/cpdm mice display skin lesions with traits similar to AD and psoriasis in humans, such as hyperkeratosis, acanthosis, dermal spongiosis, and keratinocyte apoptosis (19, 34) . Along with dermatitis, cpdm mice develop systemic inflammation and adaptive immune defects, such as splenomegaly, disrupted secondary lymphoid organ development, and inflammatory infiltrates throughout the body. Skin disease in cpdm mice was initially considered a model of human AD, given the similar histopathological findings, the prominent Th2 cytokine profile in the skin and spleen, and the associated eosinophilia (35) . However, the observations that neither depletion of eosinophils via neutralizing anti-IL-5 Ab administration (36) nor genetic ablation of IL-4R and IL-13R (37) alleviated skin inflammation suggested that type 2 immune responses could be manifestations of alternate mechanisms driving skin disease. This is unlike AD, in which neutralizing the IL-4R common a subunit proved to be of high therapeutic value in human patients (38) . TNF-mediated cell death pathways play a critical role in cpdm disease pathogenesis, because genetic loss of Tnf (31) or transgenic expression of a kinasedead Ripk1 (39) , which is capable of inducing apoptosis but not necroptosis, rescued cpdm skin disease. Loss of IL-1RAP, a common adaptor of IL-1R and IL-33R, also was shown to attenuate skin inflammation, implicating these inflammatory pathways in disease pathogenesis (40) .
Although these studies provide important genetic insights into the role of cell death in inflammatory disease, it remains unclear what pathways are engaged by Sharpin deficiency upstream of, or in parallel with, TNF-induced cell death. In this article, we demonstrate that the inflammasome pathway is an important mediator of skin disease in Sharpin cpdm/cpdm mice and may act upstream of apoptotic and necroptotic cell death. 
Materials and Methods

Animal strains
Tissue processing and Western blotting
Sections (1.5 3 1.5 cm) of shaved dorsal skin were excised and flash frozen for later use. Skin was homogenized in 1.2 ml ice-cold lysis buffer (50 mM HEPES-NaOH [pH 7.5], 100 mM NaCl, 2 mM EDTA, 10% glycerol, 0.1% CHAPS) supplemented with 10 mM sodium fluoride, 2 mM sodium orthovanadate, 10 mM b-glycerophosphate, and complete protease inhibitors (Roche), using a GLH homogenizer. After 30 min on ice, homogenized samples were subjected to four freeze-thaw cycles, followed by sonication (3 3 15 s at 80% amplitude). Following three rounds of centrifugation (13,000 3 g for 20 min) to pellet debris and remove lipids, proteins in the supernatant were quantified using the Bradford assay, and samples were diluted to 2 mg/ml with lysis buffer. A total of 20-40 mg lysate was separated by SDS-PAGE and transferred to nitrocellulose membranes. Membranes were blocked in 5% milk in 0.1% TBS-Tween 20 for 1 h at room temperature followed by overnight incubation with primary Ab at 4˚C with the following Abs: anti-caspase-1 p20 (Genentech; 
Quantitative real-time PCR
Total RNA was extracted from 1.5 3 1.5-cm shaved skin sections by homogenization in TRIzol reagent, followed by chloroform extraction and isopropanol precipitation. A total of 1.0 mg RNA was reverse transcribed into cDNA using random hexamers and MML-V Reverse Transcriptase in a total volume of 20 ml, according to the manufacturer's protocol. Quantitative PCR was performed using iTaq SYBR Green SuperMix; following normalization to the housekeeping gene Tbp or Gapdh, fold induction over wild-type was calculated using the 2 2DDCt method. Primer sequences are listed in Supplemental 
Histology
Skin, spleen, and liver sections were fixed in 10% buffered formalin overnight and embedded in paraffin, and 4-mm-thick sections were cut onto glass slides and processed for H&E staining. H&E sections were scanned using a ScanScope XT digital scanner (Aperio Technologies). Histopathological analysis was performed using H&E-stained slides by a trained veterinary pathologist (J.-M.L.) blinded to genotype. The changes observed (hyperkeratosis, parakeratosis, intracorneal pustules, acanthosis, apoptotic keratinocytes, spongiosis, erosion and ulceration, dermalepidermal interface edema and disarray, pigmentary incontinence, fibrosis and granulation, and inflammatory infiltrates in the epidermis, dermis, and subcutis) were graded using a 0 to 4 scale, where 0 is normal/absent and 4 is extreme/severe, culminating in a maximum dermatitis score of 56. Epidermal thickness was measured from at least five randomly selected fields/mouse using ImageScope (Aperio Technologies). To identify mast cells, paraffin-embedded skin sections were deparaffinized, rehydrated with distilled water, stained with a toluidine blue/sodium chloride solution (pH 2.3) for 3 min, and dehydrated with 95 and 100% ethanol, followed by clearing in xylene. Slides were scanned using a ScanScope XT digital scanner (Aperio Technologies).
Immunofluorescence staining and quantification
Following deparaffinization and Ag retrieval, slides were permeabilized with 0.25% Triton X-100 in PBS for 20 min at room temperature. Click-iT TUNEL Alexa Fluor 647 (Invitrogen; cat. no. C10247) staining was performed, according to the manufacturer's instructions. Slides were blocked (10% FBS, 3% BSA) for 30 min at 37˚C, and tissues were incubated with primary Abs against active caspase-3 (R&D Systems; cat. no. AF835) in PBS containing 3% BSA for 90 min at 37˚C, followed by a 30-min incubation with Alexa Fluor 594 (Invitrogen)-coupled secondary Abs. The slides were rinsed with PBS and stained with Hoechst 33342 (Invitrogen; cat. no. H3570). Tissues were mounted with cover slips and analyzed on a Zeiss Axioskop upright wide-field microscope. ImageJ 1.46 (National Institutes of Health) was used for processing of entire images before cropping to emphasize the main point of the image when appropriate; processing was limited to background subtraction, brightness/contrast adjustments, and pseudo colors addition to facilitate the visualization/ interpretation of the results.
To quantify cell death, we used Volocity 6.0 (Quorum Technologies) to perform object-based analysis. Briefly, the epidermal layer (excluding the stratum corneum) was selected from epifluorescence images of skin sections stained with cell death markers (apoptosis: active caspase-3 [red], late apoptosis and nonapoptotic cell death: TUNEL [far-red]). Fluorescent objects (representing cells) in both channels were found by applying a set threshold, and objects were delineated using a segmentation procedure based on a watershed algorithm. The number of active caspase-3-only, TUNEL-only, or double-positive cells was determined and expressed as the number of dead cells/mm 2 of epidermis area. Images were collected, and image processing and analysis for this manuscript were performed at the McGill University Life Sciences Complex Advanced BioImaging Facility.
Skin disease scoring
The severity of dermatitis was scored by evaluating the regions affected (head, neck, and/or back; front limbs and/or ventral area; hindlimbs and/or rump), with each affected region scoring 1 point, with the exception of the head (2 points), for a maximum of 5 points. The severity of lesions was evaluated and graded from 0 to 3, as follows: 0 = no lesion, 1 = mild scaling and hair loss, 2 = erosion and mild ulceration, and 3 = coalescent ulcerations (.5 mm). The score for the number of regions affected was added to the score for the severity of the lesions for a maximum score of 8. Clinical end point was considered a score $ 5 or the presence of corneal ulceration.
Flow cytometry staining
Splenocytes were stained with viability dye (LIVE/DEAD Fixable Aqua Dead cell stain kit; Molecular Probes) and the following Abs in PBS containing 2% FBS for 20 min: B220-allophycocyanin (clone RA3-6B2; eBioscience), NK1.1-PerCP-Cy5.5 (PK136; eBioscience), CD11c-FITC (HL3; BD Biosciences), CD11b-eFluor 450 (M1/70; eBioscience), Ly6C-PE (HK1.4; eBioscience), Ly6G-PE-Cy7 (1A8; BioLegend), and TCRb-PerCP-Cy5.5 (H57-597; eBioscience). Cells were washed in PBS containing 2% FBS and fixed with PBS containing 2% formaldehyde. Samples were analyzed on a FACSCanto II (BD Biosciences), and data were analyzed using FlowJo vX0.7.
Primary bone marrow-derived macrophage culture and stimulation
Bone marrow-derived macrophages were isolated, cultured, and stimulated as previously described (43) .
Statistical analysis
Data are shown as mean 6 SE. The two-tailed Student t test was used for evaluating statistical significance between two groups. One-way ANOVA followed by the Bonferroni post hoc comparison test was used to evaluate statistical significance among three or more groups.
Results
Early activation of inflammasome signaling in the skin of cpdm mice
To uncouple causative and consequential processes that occur in cpdm mice, we sought to examine the inflammatory milieu of the skin prior to overt disease onset. At weaning, 3-4 wk-old cpdm mice were indistinguishable in appearance from their Sharpin +/+ and Sharpin cpdm/+ littermates (Fig. 1A) , although mild epidermal hyperplasia and inflammatory cell recruitment in cpdm mice were already apparent by H&E staining (Fig. 1B, 1C) . The absence of splenomegaly in 3-4-wk-old cpdm mice suggested that systemic immunological disease had not fully developed at this early time point (Fig. 1D) . Despite the lack of overt lesions, skin explants from cpdm mice contained higher levels of IL-1 family cytokines (i.e., IL1b, IL-18, and the alarmin IL-33) compared with Sharpin cpdm/+ littermates (Fig. 1E) , with no significant differences in other cytokines known to initiate type II cytokine-driven diseases, such as TSLP (data not shown). At this time point, no significant differences in gene expression in the skin of these cytokines or other type I or II cytokines were found (Fig. 1F) . Because IL-1b and IL-18 are regulated by the inflammasome and inflammatory caspases-1 and -11 at the posttranslational level, and because their increased levels in cpdm skin could not be explained by enhanced gene expression, we posited that the inflammasome pathway might be engaged in the skin of these animals. To test this hypothesis, we performed immunoblot analysis to determine the expression and activation levels of various inflammasome pathway components. Fig. 1G shows increased expression and processing of inflammatory caspase-1 and -11 and enhanced processing of IL-18 in the skin, indicative of inflammasome activation. Because LUBAC regulates cell death downstream of TNF signaling, which was implicated in cpdm skin disease pathogenesis (39, 44, 45) , we examined, in parallel, the levels of cell death effectors in the skin of young cpdm mice. The kinases Ripk1 and Ripk3, which are involved in both apoptosis and necroptosis, also were induced in cpdm skin (Fig. 1G) . Consistently, the pronecrotic effector Mlkl was slightly induced, and proapoptotic caspase-3 and -8 were more notably activated and cleaved in the skin of young cpdm animals (Fig. 1G) . Collectively, these results indicate that activation of cell death and inflammasome pathways are early events that occur prior to overt skin disease manifestations and may be important drivers of pathology.
Inflammatory caspase-1 and -11 mediate cpdm skin pathology
To examine the role of the inflammatory caspases in cpdm pathology, we crossed cpdm mice with Ice 2/2 mice, which are deficient in both caspase-1 and -11 (46) . Strikingly, at 8 wk of age, when cpdm mice are typically nearing clinical end point in our facility and require euthanasia, age-matched cpdm; Ice 2/2 compound mutant mice were completely free of skin lesions ( Fig. 2A) . H&E staining revealed the absence of epidermal hyperplasia (Fig. 2B, 2C ), and histological analysis identified an almost complete lack of microscopic disease traits typically observed in the skin of cpdm mice, such as hyperkeratosis, parakeratosis, acanthosis, dermal-epidermal interface edema, and dermal fibrosis (Fig. 2D ). Qualitative examination of inflammatory infiltrates in the dermis of cpdm and cpdm; Ice 2/2 mice revealed the most striking difference to be a paucity of macrophages in the skin of the compound mutant mice compared with cpdm mice (Fig. 2E ). This was supported by decreased mRNA expression of Emr1 (F4/80) (Supplemental Fig. 1 ). Similar to monocytes and macrophages, staining skin sections with toluidine blue revealed that mast cells numbers also were decreased (Fig. 2F) . Consistent with inflammasome activation in cpdm skin, skin organ cultures from diseased cpdm mice contained significantly higher levels of IL-1b and IL-18 compared with wild-type mice, which were sharply decreased in age-matched cpdm; Ice 2/2 compound mutants (Fig. 2G) . Interestingly, the danger-associated molecular pattern IL-1a, although not a direct substrate of the inflammatory caspases, also was slightly decreased in the compound mutants, whereas caspase-1 and -11 deficiency had varying effects on IL-33 levels (Fig. 2G) . The elevated expression of type II cytokines documented in cpdm mice also was reversed to wild-type levels with the loss of caspase-1 and -11, whereas that of type I cytokines, with the exception of Il1b, was largely unaffected (Supplemental Fig. 1 ). In addition to dampening cytokine production, inflammatory caspase deficiency rescued the excessive keratinocyte proliferation seen in cpdm mice, as evidenced in cpdm; Ice 2/2 mice by a relative decrease in mRNA expression of keratin-14, (Supplemental Fig. 1) . Together, these
The Journal of Immunologyresults indicate a critical role for the inflammatory caspases in mediating dermatitis in cpdm mice. Despite the reduction in inflammasome-dependent cytokines in the circulation (Fig. 2H) , and in striking contrast to the impact of the inflammatory caspases on the skin phenotype, systemic disease was largely unaffected in cpdm; Ice 2/2 mice, as noted by elevated serum KC levels (Fig. 2I) , splenomegaly (Fig. 2J) , and aberrant secondary lymphoid architecture (Supplemental Fig. 2A ). Flow cytometric analysis of the spleen revealed an expansion of myeloid cells with prominent eosinophilia and a relative decrease in B and T cell frequencies in cpdm mice. Notably, the lack of caspase-1 and -11 in cpdm; Ice 2/2 mice had no effect on the examined splenic cell composition (Supplemental Fig. 2C, 2D) . Interestingly, histological analysis of liver sections from cpdm mice revealed prominent perivascular inflammatory infiltrates that were notably less abundant and reduced in size in cpdm; Ice 2/2 mice (Supplemental Fig. 2B ). These data suggest that caspase-1 and -11 primarily control skin disease progression, with intermediate tissue-specific effects on systemic disease.
Inflammasome activation lies upstream of cell death signaling in cpdm dermatitis
Given our previous observations that both the inflammasome and cell death effectors were activated early in cpdm mice prior to overt skin disease manifestation, we sought to investigate whether loss of caspase-1 and -11 modulated the expression and activation of apoptosis and necroptosis effectors and, consequently, cell death induction in the skin. Strikingly, the upregulation of Mlkl, Ripk1, and Ripk3 in the skin of cpdm mice was strongly reduced in cpdm; Ice 2/2 compound mutant mice (Fig. 3A) . This was accompanied by diminished activation and cleavage of caspase-8 and -3 (Fig. 3A) . Concordantly, immunofluorescence staining revealed a significant reduction in cleaved caspase-3 + , TUNEL + , and double-positive staining cells in the epidermis (Fig. 3B, 3C) . Overall, these data suggest that inflammasome signaling contributes to the inflammatory milieu via cytokine production, as well as to the induction of various cell death pathways in the context of cpdm skin pathology. 
Downloaded from
Ablation of inflammasome signaling delays cpdm skin disease and attenuates its severity
To determine whether skin disease eventually manifests in cpdm; Ice 2/2 compound mutant mice over time, we aged a cohort of mice beyond 8 wk. In contrast to cpdm mice, which exhibited severe skin disease by 10 wk of age, cpdm; Ice 2/2 mice showed only mild signs of disease (Fig. 4A, 4B) , with focal lesions beginning to appear in the thoracic dorsal region. Although the severity of disease slowly progressed over time, lesions were largely confined to the same region by 14 wk of age. At this time, induration of the region, scaling, and concomitant mild ulceration developed. Severe dermatitis developed much later in cpdm; Ice 2/2 mice compared with cpdm mice (Fig. 4B ), although this analysis was complicated by the development of corneal ulcerations in several compound mutant mice that necessitated euthanasia prior to severe disease onset. Interestingly, although alopecia typically manifests as a precursor of inflammation in cpdm mice, hair loss in cpdm; Ice 2/2 mice occurred uniquely as a consequence of inflammatory lesion formation and was not observed in noninflamed regions. This finding is supported by a previous report implicating caspase-1 activation in androgenetic alopecia in humans (47) . Next, to define which inflammasome sensor contributed to the activation of the inflammatory caspases in the skin, we generated cpdm mice deficient in the inflammasome scaffolding receptor Nlrp3, a well-described sensor of both microbial and endogenous danger signals. Unlike cpdm; Ice 2/2 mice, certain cpdm; Nlrp3 2/2 mice began showing mild skin disease by 8 wk of age (Fig. 4A) . Nevertheless, disease progression was notably blunted compared with cpdm mice, with some mice developing severe focal lesions with similar anatomical confinement as seen with cpdm; Ice 2/2 mice by 12 wk of age. By 16 wk of age, one of five examined cpdm; Nlrp3 2/2 mice, although significantly runted, had not developed any visible skin lesions. The onset of severe dermatitis also was delayed significantly compared with cpdm mice (Fig. 4B) . Overall, our results indicate that the absence of inflammasome signaling delays skin disease onset and attenuates disease progression.
Attenuated inflammasome activation in cpdm macrophages
Because we noted a relative loss of macrophage infiltration in the dermis of cpdm; Ice 2/2 mice and a corresponding decrease in IL1b and IL-18 secretion, we hypothesized that infiltrating macrophages might be responsible for the enhanced inflammasome response observed in the diseased skin of cpdm mice. To test this hypothesis, we set out to determine whether LUBAC impairment directly impacted the inflammasome pathway in isolated primary macrophages. Treatment of bone marrow-derived macrophages from cpdm mice with a panel of inflammasome agonists induced significantly blunted IL-1b secretion downstream of Nlrp3, Nlrc4, and Aim2 inflammasome activation (Supplemental Fig. 3A) . This was likely due to a defect in priming, as reflected by decreased pro-IL-1b expression following LPS treatment (Supplemental Fig. 3B ). In contrast to IL-1b, we observed a small, but consistent, increase in IL-18 secretion downstream of Nlrc4 or Aim2 stimulation in cpdm macrophages (Supplemental Fig. 3C ). No differences in pyroptosis were observed (Supplemental Fig. 3D ). These results are in line with recent studies demonstrating a role for LUBAC in controlling the priming step of the NLRP3 inflammasome in ex vivo macrophages (48) . Further, they suggest that alternative priming mechanisms, independent of LUBAC function in the NF-kB pathway, are engaged in vivo, allowing full inflammasome activation or that macrophages are not the primary pathogenic cell type in cpdm skin.
Discussion
Inflammatory skin disease is multifactorial and is likely driven by several inflammatory and cell death processes occurring in parallel. It was reported recently that dermatitis of cpdm mice is initiated through TNFR1-dependent cell death, because genetic ablation of Tnfr1 from cpdm mice prevented skin disease manifestation up to 35 wk of age (45) . However, although it is agreed that TNFinduced cell death is pathogenic in this context, there is a discrepancy about the primary cell death modality that drives cpdm skin pathology (39, 44) . Because both apoptosis and necroptosis are induced by TNF in cpdm keratinocytes ex vivo (31), it is conceivable that they are both detrimental. By examining young cpdm mice prior to the onset of overt disease, we showed that upregulation of inflammasome signaling is not a consequence of an established inflammatory milieu but, rather, is an important initiating signal in disease pathogenesis. However, it is worth noting that the increased IL-18 detected in skin organ culture supernatants may be attributable, in part, to the moderate keratinocyte expansion observed in these young mice and crossreactivity to the proform of IL-18 (Fig. 1B, 1C) , although other epithelial-derived cytokines, such as TSLP, were not significantly elevated (data not shown). The function of inflammasome activation as an initiating signal is supported by the significant attenuation of dermatitis and inflammatory skin lesions in cpdm; Ice 2/2 compound mutant mice.
Hyperactivation of the inflammatory caspases in the skin of cpdm mice may be a result of cell-intrinsic or cell-extrinsic interactions between Sharpin and the inflammasome. Genetic deficiency of Sharpin may sensitize mice to aberrant reactions to environmental factors that subsequently trigger inflammasome activation. Likewise, predisposition of LUBAC-deficient cells to TNFR1-mediated cell death, in particular necroptosis, could release danger-associated molecular patterns known to trigger inflammasome activation (49) . We observed an upregulation of both cell death and inflammasome effectors in cpdm skin before the appearance of outward signs of disease (Fig. 1G) , supporting the possibility that very early inflammatory cell death triggers inflammasome activation, initiating a local inflammatory environment. However, if caspase-1 and -11 were activated solely downstream of cell death, their loss should not influence cell death execution. Interestingly, our observation that the induction of both apoptotic and necroptotic effectors was impaired in cpdm; Ice 2/2 mice, despite genetic susceptibility, places the inflammasome upstream of TNF-driven cell death. Indeed, recent evidence suggests that caspase-1 can act upstream of UVB-induced apoptosis in human keratinocytes (50) . Given the intimate association between these pathways and the recent reports highlighting crossregulatory roles of cell death effectors in inflammasome activation (51) (52) (53) (54) (55) (56) , our findings may provide insight into how this crossregulation contributes to inflammatory disease in vivo.
Alternatively, Sharpin could impose a direct negative regulation on caspase activity. Although our data and that of other investigators (48) do not support such a function in macrophages, it is plausible that LUBAC might differentially modulate inflammasome activation in other cell types, such as keratinocytes. Humans with mutations in HOIL1 develop waves of systemic inflammation followed by bouts of immune deficiency, leading to hypersusceptibility to viral and bacterial infections (57) . Interestingly, these paradoxical pro-and anti-inflammatory states were attributed to cell type-specific roles for LUBAC, in which LUBAC deficiency led to hyperinflammation in monocytes but abrogated inflammation in fibroblasts. Cpdm bone marrow does not transfer disease to wild-type mice (44, 58) , and cpdm skin grafts transplanted onto nude mice retain their diseased state (59), two findings that highlight the potential pathogenic role of skin-resident cells in this context.
Incomplete rescue by loss of Nlrp3 may suggest the involvement of other inflammasome sensors upstream of caspase activation or noninflammasome functions of caspase-11; however, we cannot ignore the possibility that the different genetic backgrounds of the compound mutants and cpdm mice account for some of the observed variability. Further, it remains unclear whether cytokine production, pyroptosis, or an undescribed pathway downstream of caspase-1 and -11 activation contributes to cpdm skin disease. Because genetic ablation of either Il1r1 (44) or Il1rap (39) was shown to attenuate skin disease and delay its onset, IL-1a/b signaling clearly contributes to pathology. Notably, transgenic overexpression of caspase-1 in keratinocytes under the keratin 14 promoter was sufficient to induce severe dermatitis that is reminiscent of eczema in humans (17) . As in cpdm mice, these mice displayed severe pruritus, excessive keratinocyte apoptosis, and
The Journal of Immunologymast cell expansion. Further, despite the lack of keratin 14 expression in splenocytes, skin-specific caspase-1 overexpression skewed splenic T cell polarization toward a Th2 phenotype. In this model, IL-18 plays a dominant role, because its genetic loss fully prevented disease, whereas the absence of IL-1b only delayed its onset (18) . Although IL-1b is known to initiate a Th1 response, IL-18-mediated control over Th1/Th2 skewing is dependent on the local cytokine milieu. Indeed, IL-18 was shown to contribute to detrimental Th2 responses in both infectious disease (60) and sterile inflammatory contexts (61) , and it was suggested as a useful biomarker to assess AD severity in humans (62, 63) ; all of these data support the notion that IL-18 may also contribute to skin disease in cpdm mice.
Although loss of caspase-1/-11 or Nlrp3 attenuated skin disease, it did not completely prevent it, highlighting the complex nature of this disease. This is further supported by the dichotomy in pathways contributing to skin inflammation versus systemic disease. For example, although we demonstrated that deficiency in caspase-1 and -11 imposes drastic effects on skin disease manifestation but has minimal effects on myeloid cell expansion in the spleen or splenic architecture, other investigators recently showed that genetic ablation of Mlkl from cpdm mice attenuated hepatic and splenic inflammation, whereas dermatitis persisted (44) . Even diseases that are monogenic in nature can be the product of multiple interacting pathways, complicating therapeutic intervention. Thus, it is important to tease apart cause from consequence to differentiate between pathogenic processes and secondary symptoms. In this article, we provide evidence that inflammasome activation is an important pathogenic process in the initiation of skin disease in cpdm mice. In the future, it will be critical to dissect which other upstream platforms mediate caspase activation in the skin and what endogenous, environmental, or microbial ligands stimulate the inflammasome. Figure 1 . Gene expression profile in WT, cpdm and cpdm; Ice -/-mice. Quantitative real-time PCR analysis of skin cDNA obtained from 7-8 weeks old WT, cpdm and cpdm; Ice -/-mice. C t values were normalized to the housekeeping gene Tbp and fold expression over mean of wild-type levels was calculated. Data points represent individual mice ± SEM. Student's t-test was used for statistical analysis. * p < 0.05, * * p < 0.01, * * * p < 0.001. 
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